5-Aminovaleric acid (5-AVA), 5-hydroxyvalerate (5HV), copolymer P(3HB-co-5HV) of 3-hydroxybutyrate (3HB) and 5HV were produced from L-lysine as a substrate by recombinant Halomonas bluephagenesis constructed based on codon optimization, deletions of competitive pathway and L-lysine export protein, and three copies of davBA genes encoding L-lysine monooxygenase (DavB) and 5-aminovaleramide amidohydrolase (DavA) inserted into its genome to form H. bluephagenesis YF117ΔgabT, which produced 16.4 g L and 67.4 g L 5-AVA in flask cultures and in 7 L bioreactor, respectively. It was able to de novo synthesize 5-AVA from glucose by L-lysine-overproducing H. bluephagenesis TD226. Corn steep liquor was used instead of yeast extract for cost reduction during the 5-AVA production. Using promoter engineering based on P mutant library for downstream genes, H. bluephagenesis YF117 harboring pSEVA341-P-yqhD produced 6 g L 5HV in shake flask growth, while H. bluephagenesis YF117 harboring pSEVA341-P-yqhD-P-phaC-abfT synthesized 42 wt% P(3HB-co-4.8 mol% 5HV) under the same condition. Thus, H. bluephagenesis was successfully engineered to produce 5-AVA and 5HV in supernatant and intracellular P(3HB-co-5HV) utilizing L-lysine as the substrate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ymben.2023.12.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!